Astronomers have investigated a puzzling binary star system in which two stars that may have formed together now show ...

New simulations show that interactions with a magnetic field can work to decrease the distance between still forming binary ...

TULPEHOCKEN TWP., Pa. - Dieffenbach's was established in 1964 in Womelsdorf, Pa., and with Gibble's, it's bringing back "nostalgia advertising" with the old Gibble's logo seen on this billboard in ...

ICE agents leave a residence after knocking on the door on Jan. 28, 2026 in Minneapolis, Minnesota. The U.S. Department of Homeland Security continues its immigration enforcement operations after two ...

An estimated one in eight adult Americans is currently taking a GLP-1 drug, according to KFF, a nonprofit focused on health care issues. The drugs, initially used for diabetes, are now often used for ...

Body-Positive Model Ashley Graham Slams 'Disheartening' Use of GlP-1s in the Fashion Industry: 'It's a Smack in the Face' Jimmy Kimmel announces change out of deference to final Colbert show Pentagon ...

Being told that AI will both destroy their job and be required to get one is driving Gen-Z into a sore spot AI Gen Z Study Perfect for investors, AI is everything and nothing simultaneously. It is a ...

A common side effect of many GLP-1 drugs is hair loss. It's creating a growing market for hair treatment products. Companies like Redken, Nutrafol and KeraFactor are leaning into the innovation and ...

A new study from the University of St Andrews suggests weight-loss drugs like Ozempic taken around pregnancy do not raise the risk of major birth defects. Published in the American Journal of ...

A 'gold standard' trial found that semaglutide helped reduce drinking in people with obesity who sought out treatment for alcohol-use disorder A new study found that taking Novo Nordisk's semaglutide, ...

The use of GLP-1 medications for weight loss continues to rise. One drawback associated with GLP-1 medications is that weight loss not only includes fat loss, but muscle loss as well. A new study ...

A 26-week, randomized, double-blind trial in Copenhagen enrolled adults 18–70 years with AUD, BMI ≥30 kg/m², ≥6 heavy-drinking days, and AUDIT >15, assigning semaglutide vs placebo 1:1. Compared with ...